Pharma & Biotech

Pentixapharm has packed a remarkable amount of activity into recent days. The radiopharmaceutical specialist is juggling a US regulatory milestone...

Bayer’s share price stalled on Wednesday, sliding 2.97 percent to €47.70, as a raft of crosscurrents pulled the stock off...

Evotec’s second profit warning in just four months has thrown the credibility of the Hamburg-based biotech into sharp relief, with...

Bayer is weaving together legal, financial, and trade initiatives at a pace that suggests a coordinated push to close the...

Ugur Sahin and Özlem Türeci built BioNTech from a Mainz lab into a global vaccine powerhouse. By the end of...

Bayer unleashed a flurry of strategic moves over the weekend that simultaneously strengthen its balance sheet, attack its biggest legal...

Novo Nordisk has opened the door to one of the world's fastest-growing diabetes markets with the launch of Awiqli in...

A string of positive clinical readouts has given Ocugen a clear narrative to bring to ophthalmology’s biggest gatherings this month....

BioNTech enters a critical stretch with no single event to anchor investor sentiment. The German biotech’s stock closed at €80.20...

The stock of Sellas Life Sciences has become a high-wire act, driven by a single, narrowing countdown: just two more...